Insider Trading Tracker: Live US Stock Disclosures & Insider Buying made on Jan 21, 2025

Advanced/Help

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Showing you 400 results sorted by most recent dates. Subscribe to see a larger data set

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Cibus Inc (Class A)	Rory B. Riggs	Director, Chief Executive Officer, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	4,000,000	4,000,000	-		-	Pre-Funded Warrant
Cibus Inc (Class A)	Rory B. Riggs	Director, Chief Executive Officer, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	4,000,000	4,000,000	-		-	Common Warrant
Humacyte Inc	Brady W. Dougan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	1,130,311	1,130,311	-		-	Stock Options (right to buy)
Humacyte Inc	Laura E. Niklason	Director, President, CEO and Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	1,130,311	1,130,311	-		-	Stock Options (right to buy)
KORU Medical Systems Inc	Joseph M. Manko	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	21 Jan 2025	1,000,000	5,887,864 (14%)	2%		0	Common Stock
KORU Medical Systems Inc	Joseph M. Manko	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	21 Jan 2025	1,000,000	0 (0%)	2%		0	Common Stock
KORU Medical Systems Inc	Joseph M. Manko	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	21 Jan 2025	1,000,000	1,000,000 (2%)	2%		0	Common Stock
Renovaro Biosciences Inc	Maurice van Tilburg	Director		21 Jan 2025	1,000,000	1,000,000	-		-	Option to purchase shares of common stock
Entravision Comm Corp (Class A)	Michael J. Christenson	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	960,000	2,362,170 (3%)	1%		0	Class A common stock
Dermata Therapeutics Inc	Gerald T. Proehl	Director, President, CEO and Chairman, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	787,402	799,508	-		-	Common Stock
Dermata Therapeutics Inc	Gerald T. Proehl	Director, President, CEO and Chairman, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	787,402	787,402	-		-	Warrant (Right to Buy)
Entravision Comm Corp (Class A)	Michael J. Christenson	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	745,000	1,745,000	-		-	Performance Units
VYNE Therapeutics Inc	David Domzalski	Director, PRESIDENT AND CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	730,000	730,000	-		-	Stock Option (right to buy)
Alx Oncology Holdings Inc	Harish Shantharam	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	600,000	600,000	-		-	Employee Stock Option (right to buy)
Alx Oncology Holdings Inc	Jason Lettmann	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	478,000	478,000	-		-	Employee Stock Option (right to buy)
Abeona Therapeutics Inc	Vishwas Seshadri	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	476,435	1,380,322 (1%)	0%		0	Common Stock
KORU Medical Systems Inc	Joseph M. Manko	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	21 Jan 2025	351,948	517,200 (1%)	0%		0	Common Stock
Trade Desk Inc (Class A)	Jeffrey Terry Green	Director, President and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 124.75 per share.	21 Jan 2025	323,807	287,882 (0%)	0%	124.7	40,394,923	Class A Common Stock
Entravision Comm Corp (Class A)	Jeffery A. Liberman	President and COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	300,000	581,762 (0%)	0%		0	Class A common stock
Entravision Comm Corp (Class A)	Mark Boelke	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	300,000	691,573 (1%)	0%		0	Class A common stock
Humacyte Inc	Dale A. Sander	CFO and Chief Corp. Deve. Off.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	283,101	283,101	-		-	Stock Options (right to buy)
Humacyte Inc	Heather Prichard	Chief Operating Officer		21 Jan 2025	283,101	283,101	-		-	Stock Options (right to buy)
Humacyte Inc	William John Scheessele	Chief Commercial Officer		21 Jan 2025	283,101	283,101	-		-	Stock Options (right to buy)
Humacyte Inc	Shamik J. Parikh	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	283,101	283,101	-		-	Stock Options (right to buy)
Humacyte Inc	Yang Cao	Chief Regulatory Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	283,101	283,101	-		-	Stock Options (right to buy)
Reliance Global Grp Inc 10-year low	Ezra Beyman	Director, Chairman and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	250,000	281,006 (0%)	0%		0	Common Stock
Renovaro Biosciences Inc	Nathen Fuentes	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	250,000	250,000	-		-	Option to purchase shares of common stock
Renovaro Biosciences Inc	Maurice van Tilburg	Director		21 Jan 2025	250,000	250,000 (0%)	0%		0	Common Stock
VYNE Therapeutics Inc	Iain A. Stuart	CHIEF SCIENTIFIC OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	230,000	230,000	-		-	Stock Option (right to buy)
VYNE Therapeutics Inc	Mutya Harsch	CHIEF LEGAL OFFICER AND GC	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	230,000	230,000	-		-	Stock Option (right to buy)
VYNE Therapeutics Inc	Tyler Zeronda	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	230,000	230,000	-		-	Stock Option (right to buy)
Entravision Comm Corp (Class A)	Jeffery A. Liberman	President and COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	230,000	330,000	-		-	Performance Units
Entravision Comm Corp (Class A)	Mark Boelke	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	230,000	330,000	-		-	Performance Units
Synchrony Financial	Brian D. Doubles	Director, See remarks	Grant, award, or other acquisition of securities at price $ 69.47 per share.	21 Jan 2025	215,231	876,051 (0%)	0%	69.5	14,952,098	Common Stock
Ardelyx Inc	David M. Mott	Director	Purchase of securities on an exchange or from another person at price $ 4.99 per share.	21 Jan 2025	199,000	1,937,765 (2%)	0%	5.0	992,672	Common Stock
Dermata Therapeutics Inc	Mary M. Fisher	Director		21 Jan 2025	196,851	196,851	-		-	Warrant (Right to Buy)
Dermata Therapeutics Inc	Mary M. Fisher	Director		21 Jan 2025	196,851	196,946	-		-	Common Stock
Definitive Healthcare Corp (Class A)	Jason Krantz	Director, Ten Percent Owner, EXECUTIVE CHAIRMAN	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	178,582	1,045,986	-		0	Class A Common Stock
Trade Desk Inc (Class A)	Jeffrey Terry Green	Director, President and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 120.86 per share.	21 Jan 2025	164,166	207,904 (0%)	0%	120.9	19,841,103	Class A Common Stock
Edgewise Therapeutics Inc	Robert Blaustein	Chief Development Officer		21 Jan 2025	160,000	160,000	-		-	Stock Options (Right to buy)
Mirum Pharma Inc	Christopher Peetz	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	153,550	153,550	-		-	Stock Option (right to buy)
Celsius Holdings Inc	William H. Milmoe	Ten Percent Owner		21 Jan 2025	150,000	0	-		-	Call Option (obligation to sell)
Celsius Holdings Inc	William H. Milmoe	Ten Percent Owner		21 Jan 2025	150,000	0	-		-	Call Option (obligation to sell)
Celsius Holdings Inc	William H. Milmoe	Ten Percent Owner		21 Jan 2025	150,000	0	-		-	Call Option (obligation to sell)
Celsius Holdings Inc	William H. Milmoe	Ten Percent Owner		21 Jan 2025	150,000	0	-		-	Call Option (obligation to sell)
Celsius Holdings Inc	William H. Milmoe	Ten Percent Owner		21 Jan 2025	150,000	0	-		-	Call Option (obligation to sell)
Celsius Holdings Inc	William H. Milmoe	Ten Percent Owner		21 Jan 2025	150,000	0	-		-	Call Option (obligation to sell)
Celsius Holdings Inc	William H. Milmoe	Ten Percent Owner		21 Jan 2025	150,000	0	-		-	Call Option (obligation to sell)
Celsius Holdings Inc	William H. Milmoe	Ten Percent Owner		21 Jan 2025	150,000	0	-		-	Call Option (obligation to sell)
Celsius Holdings Inc	William H. Milmoe	Ten Percent Owner		21 Jan 2025	150,000	0	-		-	Call Option (obligation to sell)
Celsius Holdings Inc	Dean Desantis	Ten Percent Owner		21 Jan 2025	150,000	0	-		-	Call Option (obligation to sell)
Celsius Holdings Inc	Dean Desantis	Ten Percent Owner		21 Jan 2025	150,000	0	-		-	Call Option (obligation to sell)
Celsius Holdings Inc	Dean Desantis	Ten Percent Owner		21 Jan 2025	150,000	0	-		-	Call Option (obligation to sell)
Abeona Therapeutics Inc	Joseph W. Vazzano	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	144,509	509,726 (0%)	0%		0	Common stock
Trade Desk Inc (Class A)	Jeffrey Terry Green	Director, President and CEO, Ten Percent Owner		21 Jan 2025	128,594	372,070 (0%)	0%		0	Class A Common Stock
Trade Desk Inc (Class A)	Jeffrey Terry Green	Director, President and CEO, Ten Percent Owner		21 Jan 2025	128,594	30,086,886	-		-	Class B Common Stock
Snowflake Inc (Class A)	Frank Slootman	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	127,247	10,095,364	-		-	Stock Option (Right to Buy)
Snowflake Inc (Class A)	Frank Slootman	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.88 per share.	21 Jan 2025	127,247	322,528	-	8.9	1,129,953	Class A Common Stock
Relay Therapeutics Inc	Sanjiv K. Patel	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 4.78 per share.	21 Jan 2025	125,000	199,548	-	4.8	597,500	Common Stock
Relay Therapeutics Inc	Sanjiv K. Patel	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 4.52 per share.	21 Jan 2025	125,000	449,548	-	4.5	565,000	Common Stock
Relay Therapeutics Inc	Sanjiv K. Patel	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 4.80 per share.	21 Jan 2025	125,000	324,548	-	4.8	600,000	Common Stock
Abeona Therapeutics Inc	Brendan M. O'Malley	SVP, General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	115,607	388,896 (0%)	0%		0	Common Stock
Alx Oncology Holdings Inc	Shelly Pinto	SVP, FINANCE AND CAO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	112,000	112,000	-		-	Employee Stock Option (right to buy)
Perella Weinberg Partners	Dietrich Becker	Director, President	Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.76 per share.	21 Jan 2025	109,705	480,406	-	25.8	2,826,001	Class A Common Stock
Trade Desk Inc (Class A)	Jeffrey Terry Green	Director, President and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 122.83 per share.	21 Jan 2025	109,350	21,935 (0%)	0%	122.8	13,431,461	Class A Common Stock
Definitive Healthcare Corp (Class A)	Richard D. Booth	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	107,480	698,738	-		0	Class A Common Stock
Alx Oncology Holdings Inc	Alan B. Sandler	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	100,000	100,000	-		-	Employee Stock Option (right to buy)
Rapid7 Inc	Corey E. Thomas	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.77 per share.	21 Jan 2025	100,000	531,469 (1%)	0%	9.8	977,000	COMMON STOCK
Rapid7 Inc	Corey E. Thomas	Director, CEO	Sale of securities on an exchange or to another person at price $ 39.38 per share.	21 Jan 2025	100,000	431,469 (0%)	0%	39.4	3,937,770	COMMON STOCK
Rapid7 Inc	Corey E. Thomas	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	100,000	0	-		-	Stock Option (Right to Buy)
Synchrony Financial	Brian D. Doubles	Director, See remarks	Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.47 per share.	21 Jan 2025	99,797	776,254 (0%)	0%	69.5	6,932,898	Common Stock
GoodRx Holdings Inc (Class A)	Scott W. Wagner	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	94,182	94,182	-		-	Deferred Stock Unit
Trade Desk Inc (Class A)	Jeffrey Terry Green	Director, President and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 123.96 per share.	21 Jan 2025	92,540	611,689 (1%)	0%	124.0	11,471,258	Class A Common Stock
Inhibikase Therapeutics Inc	Garth Lees-Rolfe	Chief Financial Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	21 Jan 2025	90,000	0	-		-	Stock Option (Right to Buy)
Inhibikase Therapeutics Inc	Garth Lees-Rolfe	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	90,000	90,000	-		-	Stock Option (Right to Buy)
Essential Properties Realty Trust Inc	Peter M. Mavoides	Director, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.41 per share.	21 Jan 2025	85,833	317,789 (0%)	0%	31.4	2,696,015	Common Stock
Payoneer Global Inc	Beatrice Ordonez	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 10.40 per share.	21 Jan 2025	85,000	2,305,245	-	10.4	883,915	Common Stock
Reliance Global Grp Inc 10-year low	Yaakov Beyman	Exec VP, Insurance Division	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	82,534	89,201 (0%)	0%		0	Common Stock
Dropbox Inc (Class A)	Andrew W. Houston	Director, Chief Executive Officer, Ten Percent Owner		21 Jan 2025	80,499	80,499 (0%)	0%		0	Class A Common Stock
Dropbox Inc (Class A)	Andrew W. Houston	Director, Chief Executive Officer, Ten Percent Owner		21 Jan 2025	80,499	67,743,629	-		-	Class B Common Stock
Dropbox Inc (Class A)	Andrew W. Houston	Director, Chief Executive Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 30.97 per share.	21 Jan 2025	80,499	0 (0%)	0%	31.0	2,492,764	Class A Common Stock
Synchrony Financial	Brian J. Wenzel	See remarks	Grant, award, or other acquisition of securities at price $ 69.47 per share.	21 Jan 2025	78,743	155,287 (0%)	0%	69.5	5,470,276	Common Stock
Dermata Therapeutics Inc	David F. Hale	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	78,741	78,741	-		-	Warrant (Right to Buy)
Dermata Therapeutics Inc	David F. Hale	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	78,741	80,957	-		-	Common Stock
Dermata Therapeutics Inc	Kyri K. Van Hoose	SVP, CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	78,741	78,741	-		-	Common Stock
Dermata Therapeutics Inc	Kyri K. Van Hoose	SVP, CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	78,741	78,741	-		-	Warrant (Right to Buy)
Velocity Fin Inc	Christopher D. Farrar	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 18.82 per share.	21 Jan 2025	77,045	654,082	-	18.8	1,449,987	Performance Stock Units
Velocity Fin Inc	Christopher D. Farrar	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 18.82 per share.	21 Jan 2025	77,045	577,037 (3%)	0%	18.8	1,449,987	Common Stock
Trade Desk Inc (Class A)	Jeffrey Terry Green	Director, President and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 121.98 per share.	21 Jan 2025	76,619	131,285 (0%)	0%	122.0	9,345,986	Class A Common Stock
Mirum Pharma Inc	Christopher Peetz	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	75,000	75,000	-		-	Performance Restricted Stock Units
Snowflake Inc (Class A)	Frank Slootman	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.88 per share.	21 Jan 2025	72,753	268,034	-	8.9	646,047	Class A Common Stock
Snowflake Inc (Class A)	Frank Slootman	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	72,753	10,222,611	-		-	Stock Option (Right to Buy)
Snowflake Inc (Class A)	Frank Slootman	Director	Sale of securities on an exchange or to another person at price $ 175.35 per share.	21 Jan 2025	71,422	196,612	-	175.4	12,524,062	Class A Common Stock
Synchrony Financial	Carol D. Juel	See remarks	Grant, award, or other acquisition of securities at price $ 69.47 per share.	21 Jan 2025	68,246	135,122 (0%)	0%	69.5	4,741,050	Common Stock
Hims & Hers Health Inc (Class A)	Melissa Baird	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.40 per share.	21 Jan 2025	67,687	774,559	-	0.4	27,075	Class A Common Stock
Hims & Hers Health Inc (Class A)	Melissa Baird	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	67,687	189,930	-		-	Stock Option (right to buy)
5E Advanced Materials Inc	Graham van’t Hoff	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	67,175	67,175	-		-	Restricted Stock Unit
Definitive Healthcare Corp (Class A)	William Moschella	Chief Product & Tech Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	66,142	486,551	-		0	Class A Common Stock
Reliance Global Grp Inc 10-year low	Ezra Beyman	Director, Chairman and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	66,000	324,688 (0%)	0%		0	Common Stock
PaySign Inc	Mark R. Newcomer	Director, CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 2.89 per share.	21 Jan 2025	61,000	9,075,886 (18%)	0%	2.9	176,089	Common Stock
Entravision Comm Corp (Class A)	Juan Navarro	Chief Revenue Officer		21 Jan 2025	60,000	268,992 (0%)	0%		0	Class A common stock
Synchrony Financial	Alberto Casellas	See remarks	Grant, award, or other acquisition of securities at price $ 69.47 per share.	21 Jan 2025	59,057	123,881 (0%)	0%	69.5	4,102,690	Common Stock
Synchrony Financial	Curtis Howse	See remarks	Grant, award, or other acquisition of securities at price $ 69.47 per share.	21 Jan 2025	59,057	159,022 (0%)	0%	69.5	4,102,690	Common Stock
Definitive Healthcare Corp (Class A)	Jason Krantz	Director, Ten Percent Owner, EXECUTIVE CHAIRMAN	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.86 per share.	21 Jan 2025	56,976	966,395	-	4.9	276,903	Class A Common Stock
Snowflake Inc (Class A)	Frank Slootman	Director	Sale of securities on an exchange or to another person at price $ 176.63 per share.	21 Jan 2025	56,555	216,500	-	176.6	9,989,310	Class A Common Stock
Definitive Healthcare Corp (Class A)	Kate Shamsuddin Jensen	CHIEF OPERATING OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	56,221	483,736	-		0	Class A Common Stock
Centessa Pharma PLC (ADR)	Saurabh Saha	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 15.76 per share.	21 Jan 2025	53,375	431,023	-	15.8	841,115	Ordinary Shares
Synchrony Financial	Jonathan S. Mothner	See remarks	Grant, award, or other acquisition of securities at price $ 69.47 per share.	21 Jan 2025	52,497	180,084 (0%)	0%	69.5	3,646,967	Common Stock
Synchrony Financial	Bart Schaller	See remarks	Grant, award, or other acquisition of securities at price $ 69.47 per share.	21 Jan 2025	52,497	102,347 (0%)	0%	69.5	3,646,967	Common Stock
Alx Oncology Holdings Inc	Jaume Pons	PRESIDENT & CSO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	50,000	50,000	-		-	Employee Stock Option (right to buy)
Celsius Holdings Inc	William H. Milmoe	Ten Percent Owner		21 Jan 2025	50,000	0	-		-	Call Option (obligation to sell)
Celsius Holdings Inc	William H. Milmoe	Ten Percent Owner		21 Jan 2025	50,000	0	-		-	Call Option (obligation to sell)
Celsius Holdings Inc	William H. Milmoe	Ten Percent Owner		21 Jan 2025	50,000	0	-		-	Call Option (obligation to sell)
Grid Dynamics Holdings Inc (Class A)	Leonard Livschitz	Director, CHIEF EXECUTIVE OFFICER	Sale of securities on an exchange or to another person at price $ 20.88 per share.	21 Jan 2025	50,000	3,041,906	-	20.9	1,044,000	Common Stock
Hims & Hers Health Inc (Class A)	Soleil Boughton	Chief Legal Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.01 per share.	21 Jan 2025	50,000	219,803	-	5.0	250,500	Class A Common Stock
Hims & Hers Health Inc (Class A)	Soleil Boughton	Chief Legal Officer	Sale of securities on an exchange or to another person at price $ 30.00 per share.	21 Jan 2025	50,000	169,803	-	30	1,500,000	Class A Common Stock
Hims & Hers Health Inc (Class A)	Soleil Boughton	Chief Legal Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	50,000	644,154	-		-	Stock Option (right to buy)
Mirum Pharma Inc	Peter Radovich	PRESIDENT AND COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	50,000	50,000	-		-	Stock Option (right to buy)
Snowflake Inc (Class A)	Frank Slootman	Director	Sale of securities on an exchange or to another person at price $ 175.39 per share.	21 Jan 2025	49,473	273,055	-	175.4	8,676,971	Class A Common Stock
W. P. Carey Inc	Jason E. Fox	Director, CEO, President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	49,235	957,413 (0%)	0%		0	Common Stock
AT&T	Lori M. Lee	Global Mktg Ofr & SEVP HR&Intl	Gift of securities by or to the insider at price $ 0.00 per share.	21 Jan 2025	49,030	0 (0%)	0%		0	Common Stock
AT&T	Lori M. Lee	Global Mktg Ofr & SEVP HR&Intl	Gift of securities by or to the insider at price $ 0.00 per share.	21 Jan 2025	49,030	49,030 (0%)	0%		0	Common Stock
Life Time Grp Holdings Inc	Ritadhwaja Jebens Singh	EVP & CHIEF DIGITAL OFFICER	Sale of securities on an exchange or to another person at price $ 28.00 per share.	21 Jan 2025	48,596	143,030	-	28	1,360,688	Common Stock
Reliance Global Grp Inc 10-year low	Scott Korman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	47,505	52,869 (0%)	0%		0	Common Stock
Reliance Global Grp Inc 10-year low	Sheldon Brickman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	47,505	52,741 (0%)	0%		0	Common Stock
Reliance Global Grp Inc 10-year low	Ben Fruchtzweig	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	47,505	52,756 (0%)	0%		0	Common Stock
5E Advanced Materials Inc	Bryn Llywelyn Jones	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	47,465	47,465	-		-	Restricted Stock Unit
CarGurus Inc (Class A)	Langley Steinert	Director, Executive Chair, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 38.40 per share.	21 Jan 2025	45,407	707,242 (0%)	0%	38.4	1,743,642	Class A Common Stock
CarGurus Inc (Class A)	Langley Steinert	Director, Executive Chair, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 38.15 per share.	21 Jan 2025	45,407	752,649 (0%)	0%	38.2	1,732,368	Class A Common Stock
Inhibikase Therapeutics Inc	Milton H. Werner	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	45,000	45,000	-		-	Stock Option (Right to Buy)
Inhibikase Therapeutics Inc	Milton H. Werner	Director, President and CEO	Sale or transfer of securities back to the company at price $ 0.00 per share.	21 Jan 2025	45,000	0	-		-	Stock Option (Right to Buy)
Velocity Fin Inc	Christopher D. Farrar	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	45,000	699,082 (3%)	0%		0	Common Stock
Entravision Comm Corp (Class A)	Juan Navarro	Chief Revenue Officer		21 Jan 2025	45,000	45,000	-		-	Performance Units
Trade Desk Inc (Class A)	Jeffrey Terry Green	Director, President and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 125.58 per share.	21 Jan 2025	44,406	243,476 (0%)	0%	125.6	5,576,505	Class A Common Stock
Sun Communities Inc	Gary A. Shiffman	Director, Chairman & CEO	Gift of securities by or to the insider at price $ 0.00 per share.	21 Jan 2025	41,039	883,077 (0%)	0%		0	COMMON STOCK, $0.01 PAR VALUE
Cricut Inc (Class A)	Ashish Arora	Director, Chief Executive Officer, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	40,787	3,736,627	-		0	Class A Common Stock
Alx Oncology Holdings Inc	Corey S. Goodman	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	40,400	40,400	-		-	Stock Option (right to buy)
Alx Oncology Holdings Inc	Barbara Klencke	Director		21 Jan 2025	40,400	40,400	-		-	Stock Option (right to buy)
Alx Oncology Holdings Inc	Chris H. Takimoto	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	40,400	40,400	-		-	Common Stock (right to buy)
Alx Oncology Holdings Inc	Rekha Hemrajani	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	40,400	40,400	-		-	Stock Option (right to buy)
Mirum Pharma Inc	Eric H. Bjerkholt	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	40,000	40,000	-		-	Stock Option (right to buy)
Mirum Pharma Inc	Joanne Quan	CHIEF MEDICAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	40,000	40,000	-		-	Stock Option (right to buy)
Trade Desk Inc (Class A)	Jeffrey Terry Green	Director, President and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 124.71 per share.	21 Jan 2025	39,797	775,231 (1%)	0%	124.7	4,963,084	Class A Common Stock
Mirum Pharma Inc	Christopher Peetz	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	38,390	38,390	-		-	Restricted Stock Units
Synchrony Financial	Brian J. Wenzel	See remarks	Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.47 per share.	21 Jan 2025	36,566	118,721 (0%)	0%	69.5	2,540,240	Common Stock
374Water Inc Board Meeting	Yaacov Nagar	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 0.59 per share.	21 Jan 2025	36,390	36,825,492	-	0.6	21,652	Common Stock
Expensify Inc (Class A)	David Barrett	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 3.32 per share.	21 Jan 2025	36,289	2,110,914	-	3.3	120,479	Class A Common Stock
Rivian Automotive Inc (Class A)	Robert J. Scaringe	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	35,713	7,713,834	-		-	Stock Option
Rivian Automotive Inc (Class A)	Robert J. Scaringe	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.63 per share.	21 Jan 2025	35,713	899,074	-	2.6	93,861	Class A Common Stock
Rivian Automotive Inc (Class A)	Robert J. Scaringe	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 13.76 per share.	21 Jan 2025	35,713	863,361	-	13.8	491,414	Class A Common Stock
Inhibikase Therapeutics Inc	Milton H. Werner	Director, President and CEO	Sale or transfer of securities back to the company at price $ 0.00 per share.	21 Jan 2025	35,000	0	-		-	Stock Option (Right to Buy)
Inhibikase Therapeutics Inc	Milton H. Werner	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	35,000	35,000	-		-	Stock Option (Right to Buy)
Onto Innovation Inc	Michael P. Plisinski	Director, CEO	Sale of securities on an exchange or to another person at price $ 219.19 per share.	21 Jan 2025	35,000	150,492 (0%)	0%	219.2	7,671,650	Common Stock
Credo Tech Grp Holding Ltd	Yat Tung Lam	Director, Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 81.12 per share.	21 Jan 2025	34,730	131,948	-	81.1	2,817,131	Ordinary Shares
Reliance Global Grp Inc 10-year low	Alex Blumenfrucht	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	33,109	33,593 (0%)	0%		0	Common Stock
Hims & Hers Health Inc (Class A)	Melissa Baird	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 29.55 per share.	21 Jan 2025	31,845	715,809	-	29.5	940,956	Class A Common Stock
JPMC Results Board Meeting	Mary Callahan Erdoes	CEO Asset & Wealth Management	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	31,504	31,504	-		-	Restricted Stock Units
5E Advanced Materials Inc	Barry Dick	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	30,709	30,709	-		-	Restricted Stock Unit
Synchrony Financial	Alberto Casellas	See remarks	Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.47 per share.	21 Jan 2025	30,581	93,300 (0%)	0%	69.5	2,124,462	Common Stock
Credo Tech Grp Holding Ltd	Yat Tung Lam	Director, Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 81.58 per share.	21 Jan 2025	30,548	101,400	-	81.6	2,492,072	Ordinary Shares
Minerals Tech Inc	Douglas T. Dietrich	Director, Chairman and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	30,098	94,943	-		-	Deferred Restricted Stock Units (DRSUs)
Inhibikase Therapeutics Inc	Dennis N. Berman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	30,000	30,000	-		-	Stock Option (Right to Buy)
Inhibikase Therapeutics Inc	Dennis N. Berman	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	21 Jan 2025	30,000	0	-		-	Stock Option (Right to Buy)
Inhibikase Therapeutics Inc	Roy Freeman	Director		21 Jan 2025	30,000	30,000	-		-	Stock Option (Right to Buy)
Inhibikase Therapeutics Inc	Roy Freeman	Director		21 Jan 2025	30,000	0	-		-	Stock Option (Right to Buy)
Blend Labs Inc (Class A)	Brian Kneafsey	Head of Revenue		21 Jan 2025	30,000	806,759	-	3.6	107,697	Class A Common Stock
Edgewise Therapeutics Inc	Robert Blaustein	Chief Development Officer		21 Jan 2025	30,000	30,000	-		-	Restricted Stock Units
Inhibikase Therapeutics Inc	Dennis N. Berman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	30,000	30,000	-		-	Stock Option (Right to Buy)
Loop Ind Inc Results Board Meeting	Laurence G. Sellyn	Director	Purchase of securities on an exchange or from another person at price $ 1.05 per share.	21 Jan 2025	29,937	197,833 (0%)	0%	1.1	31,434	Common Stock
Synchrony Financial	Carol D. Juel	See remarks	Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.47 per share.	21 Jan 2025	29,557	105,565 (0%)	0%	69.5	2,053,325	Common Stock
Credo Tech Grp Holding Ltd	Chi Fung Cheng	Director, Chief Technology Officer	Sale of securities on an exchange or to another person at price $ 81.25 per share.	21 Jan 2025	28,690	8,279,274	-	81.2	2,331,005	Ordinary Shares
Definitive Healthcare Corp (Class A)	William Moschella	Chief Product & Tech Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.86 per share.	21 Jan 2025	28,538	451,302	-	4.9	138,695	Class A Common Stock
Allstate	Thomas J. Wilson	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 192.20 per share.	21 Jan 2025	28,203	95,007 (0%)	0%	192.2	5,420,608	Common Stock
Allogene Therapeutics Inc	Zachary Roberts	EVP of R&D	Sale of securities on an exchange or to another person at price $ 1.78 per share.	21 Jan 2025	27,199	488,054 (0%)	0%	1.8	48,414	Common Stock
Definitive Healthcare Corp (Class A)	Richard D. Booth	CHIEF FINANCIAL OFFICER	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.86 per share.	21 Jan 2025	27,080	661,466	-	4.9	131,609	Class A Common Stock
PaySign Inc	Mark R. Newcomer	Director, CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 2.88 per share.	21 Jan 2025	27,000	9,048,886 (18%)	0%	2.9	77,755	Common Stock
Tejon Ranch Co.	Allen E. Lyda	Executive Vice President/ COO	Grant, award, or other acquisition of securities at price $ 15.90 per share.	21 Jan 2025	26,586	228,748 (0%)	0%	15.9	422,717	Tejon Ranch Co. Common Stock
JPMC Results Board Meeting	Troy L. Rohrbaugh	Co-CEO CIB	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	26,349	26,349	-		-	Restricted Stock Units
Minerals Tech Inc	Douglas T. Dietrich	Director, Chairman and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	25,848	25,848	-		-	Employee Stock Option (Right to Buy)
USCB Fin Holdings Inc (Class A)	Luis de la Aguilera	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	25,653	241,527	-		0	Class A Voting Common Stock
Synchrony Financial	Curtis Howse	See remarks	Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.47 per share.	21 Jan 2025	25,635	133,387 (0%)	0%	69.5	1,780,863	Common Stock
eXp World Holdings Inc	Glenn Sanford	Director, CEO and Chairman of the Board, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 11.44 per share.	21 Jan 2025	25,000	40,097,450 (62%)	0%	11.4	285,905	Common Stock
RH (Class A) Insider Trade	Eri Chaya	Director, SEE REMARKS	Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.42 per share.	21 Jan 2025	25,000	25,000 (0%)	0%	39.4	985,500	Common Stock
RH (Class A) Insider Trade	Eri Chaya	Director, SEE REMARKS	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	25,000	50,000	-		-	Stock Option (Right to Buy)
Harmony Biosciences Holdings Inc	Sandip S. Kapadia	CHIEF FINANCIAL OFFICER		21 Jan 2025	25,000	0	-	40.2	1,004,598	Common Stock
Harmony Biosciences Holdings Inc	Sandip S. Kapadia	CHIEF FINANCIAL OFFICER		21 Jan 2025	25,000	205,000	-		-	Stock Option
Harmony Biosciences Holdings Inc	Sandip S. Kapadia	CHIEF FINANCIAL OFFICER		21 Jan 2025	25,000	25,000	-	29.0	725,750	Common Stock
Power Soln Intl Inc	Gary Winemaster	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 40.63 per share.	21 Jan 2025	24,900	2,956,219 (12%)	0%	40.6	1,011,779	Common Stock
Intrepid Potash Inc	Robert P. Jornayvaz	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 26.93 per share.	21 Jan 2025	24,567	104,663 (0%)	0%	26.9	661,589	Common Stock
Synchrony Financial	Jonathan S. Mothner	See remarks	Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.47 per share.	21 Jan 2025	24,417	155,667 (0%)	0%	69.5	1,696,249	Common Stock
MeiraGTx Holdings PLC	Richard Giroux	CFO & COO	Sale of securities on an exchange or to another person at price $ 6.29 per share.	21 Jan 2025	24,000	849,947 (2%)	0%	6.3	150,960	Ordinary Shares
JPMC Results Board Meeting	Marianne Lake	CEO CCB	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	23,485	23,485	-		-	Restricted Stock Units
JPMC Results Board Meeting	Jennifer A Piepszak	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	23,485	23,485	-		-	Restricted Stock Units
Meta High Gain High Volume	Mark Zuckerberg	Director, COB and CEO, Ten Percent Owner		21 Jan 2025	22,946	193,433,308	-		-	Class B Common Stock
Meta High Gain High Volume	Mark Zuckerberg	Director, COB and CEO, Ten Percent Owner		21 Jan 2025	22,946	22,946 (0%)	0%		0	Class A Common Stock
Definitive Healthcare Corp (Class A)	Jason Krantz	Director, Ten Percent Owner, EXECUTIVE CHAIRMAN	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.41 per share.	21 Jan 2025	22,615	1,023,371	-	4.4	99,732	Class A Common Stock
Reliance Global Grp Inc 10-year low	Ezra Beyman	Director, Chairman and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.96 per share.	21 Jan 2025	22,318	258,688 (0%)	0%	2.0	43,667	Common Stock
Morgan Stanley Results Board Meeting	Daniel A. Simkowitz	Co-President	Sale of securities on an exchange or to another person at price $ 136.22 per share.	21 Jan 2025	22,111	438,249 (0%)	0%	136.2	3,011,907	Common Stock
Expensify Inc (Class A)	David Barrett	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 3.31 per share.	21 Jan 2025	21,966	2,088,948	-	3.3	72,707	Class A Common Stock
RH (Class A) Insider Trade	Eri Chaya	Director, SEE REMARKS	Sale of securities on an exchange or to another person at price $ 450.21 per share.	21 Jan 2025	21,870	3,130 (0%)	0%	450.2	9,846,099	Common Stock
Inhibikase Therapeutics Inc	Dennis N. Berman	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	21 Jan 2025	21,854	0	-		-	Stock Option (Right to Buy)
Inhibikase Therapeutics Inc	Dennis N. Berman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	21,854	21,854	-		-	Stock Option (Right to Buy)
Inhibikase Therapeutics Inc	Roy Freeman	Director		21 Jan 2025	21,854	0	-		-	Stock Option (Right to Buy)
Inhibikase Therapeutics Inc	Roy Freeman	Director		21 Jan 2025	21,854	21,854	-		-	Stock Option (Right to Buy)
Inhibikase Therapeutics Inc	Dennis N. Berman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	21,854	21,854	-		-	Stock Option (Right to Buy)
JPMC Results Board Meeting	Douglas B. Petno	Co-CEO CIB	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	21,766	21,766	-		-	Restricted Stock Units
Phreesia Inc	Chaim Indig	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 27.31 per share.	21 Jan 2025	21,692	1,237,538 (3%)	0%	27.3	592,424	Common Stock
Mirum Pharma Inc	Peter Radovich	PRESIDENT AND COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	21,660	21,660	-		-	Performance Restricted Stock Units
Reliance Global Grp Inc 10-year low	Ezra Beyman	Director, Chairman and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.88 per share.	21 Jan 2025	21,495	303,193 (0%)	0%	1.9	40,443	Common Stock
Cricut Inc (Class A)	Ashish Arora	Director, Chief Executive Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 5.86 per share.	21 Jan 2025	21,250	3,694,127	-	5.9	124,461	Class A Common Stock
Cricut Inc (Class A)	Ashish Arora	Director, Chief Executive Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 5.79 per share.	21 Jan 2025	21,250	3,715,377	-	5.8	123,108	Class A Common Stock
Cricut Inc (Class A)	Ashish Arora	Director, Chief Executive Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 5.75 per share.	21 Jan 2025	21,250	3,695,840	-	5.8	122,249	Class A Common Stock
Snowflake Inc (Class A)	Frank Slootman	Director	Sale of securities on an exchange or to another person at price $ 177.23 per share.	21 Jan 2025	21,219	195,281	-	177.2	3,760,622	Class A Common Stock
Bed Bath & Beyond Inc	David J. Nielsen	PRESIDENT	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	20,964	83,901 (0%)	0%	0.0	2	Common Stock
Bed Bath & Beyond Inc	David J. Nielsen	PRESIDENT	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	20,964	20,965	-		-	Restricted Stock Units
Bed Bath & Beyond Inc	Adrianne B. Lee	CHIEF FINANCIAL&ADMIN. OFFICER		21 Jan 2025	20,964	20,965	-		-	Restricted Stock Units
Bed Bath & Beyond Inc	Adrianne B. Lee	CHIEF FINANCIAL&ADMIN. OFFICER		21 Jan 2025	20,964	69,350 (0%)	0%	0.0	2	Common Stock
Inhibikase Therapeutics Inc	Milton H. Werner	Director, President and CEO	Sale or transfer of securities back to the company at price $ 0.00 per share.	21 Jan 2025	20,834	0	-		-	Stock Option (Right to Buy)
Inhibikase Therapeutics Inc	Milton H. Werner	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	20,834	20,834	-		-	Stock Option (Right to Buy)
Synchrony Financial	Bart Schaller	See remarks	Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.47 per share.	21 Jan 2025	20,641	81,706 (0%)	0%	69.5	1,433,930	Common Stock
Buckle Inc Dividend	Dennis H. Nelson	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 48.07 per share.	21 Jan 2025	20,453	1,719,281 (3%)	0%	48.1	983,274	Common Stock
Loop Ind Inc Results Board Meeting	Laurence G. Sellyn	Director	Purchase of securities on an exchange or from another person at price $ 1.15 per share.	21 Jan 2025	20,063	217,896 (0%)	0%	1.1	23,072	Common Stock
Progressive	Susan Patricia Griffith	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	19,982	41,525	-		-	Restricted Stock Unit
Progressive	Susan Patricia Griffith	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	19,982	493,717 (0%)	0%		0	Common
374Water Inc Board Meeting	Yaacov Nagar	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 0.59 per share.	21 Jan 2025	19,772	36,805,720	-	0.6	11,685	Common Stock
Williams-Sonoma	Laura J. Alber	Director, PRESIDENT & CEO	Sale of securities on an exchange or to another person at price $ 207.65 per share.	21 Jan 2025	19,616	959,137 (1%)	0%	207.6	4,073,262	Common Stock
Harmony Biosciences Holdings Inc	Jeffrey M. Dayno	Director, PRESIDENT, CEO	Sale of securities on an exchange or to another person at price $ 40.13 per share.	21 Jan 2025	19,293	0	-	40.1	774,245	Common Stock
Harmony Biosciences Holdings Inc	Jeffrey M. Dayno	Director, PRESIDENT, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.22 per share.	21 Jan 2025	19,293	19,293	-	8.2	158,588	Common Stock
GoodRx Holdings Inc (Class A)	Scott W. Wagner	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	19,217	317,850	-		0	Class A Common Stock
Phathom Pharma Inc	Terrie Curran	Director, President and Chief Executive	Sale of securities on an exchange or to another person at price $ 6.59 per share.	21 Jan 2025	19,109	360,465 (1%)	0%	6.6	125,884	Common Stock
Morgan Stanley Results Board Meeting	Andrew M. Saperstein	Co-President	Sale of securities on an exchange or to another person at price $ 136.07 per share.	21 Jan 2025	18,833	338,994 (0%)	0%	136.1	2,562,557	Common Stock
Snowflake Inc (Class A)	Benoit Dageville	Director, President of Products	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.74 per share.	21 Jan 2025	18,750	66,460	-	0.7	13,875	Class A Common Stock
Snowflake Inc (Class A)	Benoit Dageville	Director, President of Products	Sale of securities on an exchange or to another person at price $ 175.00 per share.	21 Jan 2025	18,750	47,710	-	175	3,281,250	Class A Common Stock
Snowflake Inc (Class A)	Benoit Dageville	Director, President of Products	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	18,750	557,363	-		-	Stock Option (Right to Buy)
JPMC Results Board Meeting	Ashley Bacon	Chief Risk Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	18,702	18,702	-		-	Restricted Stock Units
JPMC Results Board Meeting	Stacey Friedman	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	18,702	18,702	-		-	Restricted Stock Units
JPMC Results Board Meeting	Jeremy Barnum	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	18,702	18,702	-		-	Restricted Stock Units
Velocity Fin Inc	Mark R. Szczepaniak	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 18.82 per share.	21 Jan 2025	18,597	152,390 (0%)	0%	18.8	349,996	Common Stock
Velocity Fin Inc	Mark R. Szczepaniak	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 18.82 per share.	21 Jan 2025	18,597	170,987	-	18.8	349,996	Performance Stock Units
Velocity Fin Inc	Jeffrey T. Taylor	Executive VP, Capital Markets	Grant, award, or other acquisition of securities at price $ 18.82 per share.	21 Jan 2025	18,597	177,812	-	18.8	349,996	Performance Stock Units
Velocity Fin Inc	Jeffrey T. Taylor	Executive VP, Capital Markets	Grant, award, or other acquisition of securities at price $ 18.82 per share.	21 Jan 2025	18,597	159,215 (0%)	0%	18.8	349,996	Common Stock
Mirum Pharma Inc	Jolanda Howe	SVP, GLOBAL CONTROLLER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	18,500	18,500	-		-	Stock Option (right to buy)
Morgan Stanley Results Board Meeting	Michael A. Pizzi	Head Technology & Operations	Sale of securities on an exchange or to another person at price $ 136.92 per share.	21 Jan 2025	18,391	137,787 (0%)	0%	136.9	2,518,164	Common Stock
SouthState Corp	John C. Corbett	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	18,144	89,851	-		-	Performance Share Units
Trade Desk Inc (Class A)	Jeffrey Terry Green	Director, President and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 120.85 per share.	21 Jan 2025	18,058	753,170 (1%)	0%	120.8	2,182,309	Class A Common Stock
Power Soln Intl Inc	Gary Winemaster	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 36.84 per share.	21 Jan 2025	17,983	2,981,119 (13%)	0%	36.8	662,427	Common Stock
Morgan Stanley Results Board Meeting	Raja J. Akram	Deputy Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 136.01 per share.	21 Jan 2025	17,500	81,439 (0%)	0%	136.0	2,380,175	Common Stock
Wayfair Inc (Class A)	Niraj Shah	Director, Chief Executive Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 48.58 per share.	21 Jan 2025	17,441	592,782 (0%)	0%	48.6	847,284	Class A Common Stock
Credo Tech Grp Holding Ltd	Yat Tung Lam	Director, Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 78.84 per share.	21 Jan 2025	17,304	176,896	-	78.8	1,364,237	Ordinary Shares
W. P. Carey Inc	ToniAnn Sanzone	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	16,880	140,806 (0%)	0%		0	Common Stock
Expensify Inc (Class A)	David Barrett	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 3.27 per share.	21 Jan 2025	16,715	2,072,233	-	3.3	54,658	Class A Common Stock
Inhibikase Therapeutics Inc	Milton H. Werner	Director, President and CEO	Sale or transfer of securities back to the company at price $ 0.00 per share.	21 Jan 2025	16,667	0	-		-	Stock Option (Right to Buy)
Inhibikase Therapeutics Inc	Milton H. Werner	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	16,667	16,667	-		-	Stock Option (Right to Buy)
Trade Desk Inc (Class A)	Jeffrey Terry Green	Director, President and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 125.09 per share.	21 Jan 2025	16,666	4,400 (0%)	0%	125.1	2,084,750	Class A Common Stock
ICF Intl Inc	John Wasson	Director, CEO & President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	16,587	16,771 (0%)	0%		0	Common
Velocity Fin Inc	Jeffrey T. Taylor	Executive VP, Capital Markets	Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.82 per share.	21 Jan 2025	16,583	176,229 (0%)	0%	18.8	312,092	Common Stock
Wayfair Inc (Class A)	Steven Conine	Director, Co-Founder, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 48.67 per share.	21 Jan 2025	16,413	591,840 (0%)	0%	48.7	798,821	Class A Common Stock
Definitive Healthcare Corp (Class A)	Kate Shamsuddin Jensen	CHIEF OPERATING OFFICER	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.86 per share.	21 Jan 2025	16,342	462,063	-	4.9	79,422	Class A Common Stock
Reliance Global Grp Inc 10-year low	Yaakov Beyman	Exec VP, Insurance Division	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	16,250	98,078 (0%)	0%		0	Common Stock
Cava Grp Inc	Brett Schulman	Director, CEO and President	Sale of securities on an exchange or to another person at price $ 119.01 per share.	21 Jan 2025	16,246	780,687	-	119.0	1,933,436	Common Stock
Velocity Fin Inc	Mark R. Szczepaniak	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.82 per share.	21 Jan 2025	16,177	169,810 (0%)	0%	18.8	304,451	Common Stock
Aura Biosciences Inc	Elisabet de los Pinos	Director, See Remarks		21 Jan 2025	15,955	304,692	-	7.7	122,381	Common Stock
Goldman Sachs Results Board Meeting	Kathryn H. Ruemmler	Chief Legal Officer, GC	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	15,937	0	-		-	Restricted Stock Units
Goldman Sachs Results Board Meeting	Kathryn H. Ruemmler	Chief Legal Officer, GC	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	15,937	25,526 (0%)	0%		-	Common Stock, par value $0.01 per share
Protara Therapeutics Inc	Jesse Shefferman	Director, CEO and President	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.76 per share.	21 Jan 2025	15,469	913,553 (15%)	0%	4.8	73,632	Common Stock
Mackenzie Realty Cap Inc	Robert E. Dixon	CEO/President	Purchase of securities on an exchange or from another person at price $ 2.56 per share.	21 Jan 2025	15,000	40,000	-	2.6	38,400	MacKenzie Realty Capital Inc. Common Stock
Urban Outfitters Inc	Harry S. Cherken	Director	Sale of securities on an exchange or to another person at price $ 50.50 per share.	21 Jan 2025	15,000	495,296 (0%)	0%	50.5	757,500	Common Shares
Velocity Fin Inc	Mark R. Szczepaniak	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	15,000	185,987 (0%)	0%		0	Common Stock
Velocity Fin Inc	Jeffrey T. Taylor	Executive VP, Capital Markets	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	15,000	192,812 (1%)	0%		0	Common Stock
Morgan Stanley Results Board Meeting	Daniel A. Simkowitz	Co-President	Sale of securities on an exchange or to another person at price $ 137.20 per share.	21 Jan 2025	14,520	423,729 (0%)	0%	137.2	1,992,161	Common Stock
Hims & Hers Health Inc (Class A)	Andrew Dudum	Director, Chief Executive Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.43 per share.	21 Jan 2025	14,269	42,187	-	2.4	34,674	Class A Common Stock
Hims & Hers Health Inc (Class A)	Andrew Dudum	Director, Chief Executive Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 30.08 per share.	21 Jan 2025	14,269	27,918	-	30.1	429,184	Class A Common Stock
Hims & Hers Health Inc (Class A)	Andrew Dudum	Director, Chief Executive Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	14,269	1,533,499	-		-	Stock Option (right to buy)
Phreesia Inc	David Linetsky	SVP, Life Sciences	Sale of securities on an exchange or to another person at price $ 27.31 per share.	21 Jan 2025	13,873	223,392 (0%)	0%	27.3	378,881	Common Stock
Hims & Hers Health Inc (Class A)	Melissa Baird	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 29.58 per share.	21 Jan 2025	13,430	756,934	-	29.6	397,278	Class A Common Stock
Tejon Ranch Co.	Allen E. Lyda	Executive Vice President/ COO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.90 per share.	21 Jan 2025	13,425	215,323 (0%)	0%	15.9	213,458	Tejon Ranch Co. Common Stock
Morgan Stanley Results Board Meeting	Sharon Yeshaya	Chief Financial Officer	Gift of securities by or to the insider at price $ 0.00 per share.	21 Jan 2025	13,295	13,295 (0%)	0%		0	Common Stock
Morgan Stanley Results Board Meeting	Sharon Yeshaya	Chief Financial Officer	Gift of securities by or to the insider at price $ 0.00 per share.	21 Jan 2025	13,295	127,655 (0%)	0%		0	Common Stock
Velocity Fin Inc	Roland T. Kelly	Chief Legal Officer and GC	Grant, award, or other acquisition of securities at price $ 18.82 per share.	21 Jan 2025	13,283	110,359	-	18.8	249,986	Performance Stock Units
Velocity Fin Inc	Roland T. Kelly	Chief Legal Officer and GC	Grant, award, or other acquisition of securities at price $ 18.82 per share.	21 Jan 2025	13,283	97,076 (0%)	0%	18.8	249,986	Common Stock
Morgan Stanley Results Board Meeting	Eric F. Grossman	Chief Legal/Admin Officer	Sale of securities on an exchange or to another person at price $ 136.20 per share.	21 Jan 2025	13,097	197,444 (0%)	0%	136.2	1,783,754	Common Stock
Airbnb	Brian Chesky	Director, CEO and Chairman, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 134.51 per share.	21 Jan 2025	13,006	12,462,447	-	134.5	1,749,480	Class A Common Stock
Darden Restaurants	Matthew R. Broad	SVP General Counsel	Sale of securities on an exchange or to another person at price $ 187.37 per share.	21 Jan 2025	12,759	14,328 (0%)	0%	187.4	2,390,707	Common Stock
Phreesia Inc	Evan Roberts	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 27.31 per share.	21 Jan 2025	12,749	755,459 (2%)	0%	27.3	348,184	Common Stock
Acumen Pharma Inc	Daniel O'Connell	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 1.59 per share.	21 Jan 2025	12,619	667,488	-	1.6	20,102	Common Stock
Vital Farms Inc	Matthew O’Hayer	Director, EXECUTIVE CHAIRPERSON, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 42.84 per share.	21 Jan 2025	12,606	7,024,984	-	42.8	540,041	Common Stock
Mirum Pharma Inc	Peter Radovich	PRESIDENT AND COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	12,500	12,500	-		-	Restricted Stock Units
Snowflake Inc (Class A)	Benoit Dageville	Director, President of Products	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	12,500	544,863	-		-	Stock Option (Right to Buy)
Snowflake Inc (Class A)	Benoit Dageville	Director, President of Products	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.74 per share.	21 Jan 2025	12,500	60,210	-	0.7	9,250	Class A Common Stock
Snowflake Inc (Class A)	Benoit Dageville	Director, President of Products	Sale of securities on an exchange or to another person at price $ 175.10 per share.	21 Jan 2025	12,500	47,710	-	175.1	2,188,750	Class A Common Stock
Insulet	Eric Benjamin	EVP, CPXPO	Sale of securities on an exchange or to another person at price $ 280.00 per share.	21 Jan 2025	12,394	11,383 (0%)	0%	280	3,470,320	Common Stock
Williams-Sonoma	Laura J. Alber	Director, PRESIDENT & CEO	Sale of securities on an exchange or to another person at price $ 208.63 per share.	21 Jan 2025	12,183	946,954 (1%)	0%	208.6	2,541,739	Common Stock
SouthState Corp	John C. Corbett	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	12,096	26,927	-		-	Restricted Share Units
Trade Desk Inc (Class A)	Jeffrey Terry Green	Director, President and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 122.84 per share.	21 Jan 2025	12,065	732,263 (1%)	0%	122.8	1,482,065	Class A Common Stock
JPMC Results Board Meeting	Lori A. Beer	Chief Information Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	12,029	12,029	-		-	Restricted Stock Units
PaySign Inc	Mark R. Newcomer	Director, CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 2.85 per share.	21 Jan 2025	12,000	9,036,886 (18%)	0%	2.8	34,141	Common Stock
Morgan Stanley Results Board Meeting	Andrew M. Saperstein	Co-President	Sale of securities on an exchange or to another person at price $ 136.99 per share.	21 Jan 2025	11,887	327,107 (0%)	0%	137.0	1,628,357	Common Stock
Zevia PBC (Class A)	Amy E. Taylor	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 4.74 per share.	21 Jan 2025	11,479	1,002,773	-	4.7	54,430	Class A Common Stock
Medtronic	Gary Corona	Interim CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	11,315	44,255 (0%)	0%		0	Ordinary Shares
Synchrony Financial	Darrell Owens	See remarks	Grant, award, or other acquisition of securities at price $ 69.47 per share.	21 Jan 2025	11,025	31,934 (0%)	0%	69.5	765,907	Common Stock
Progressive	Susan Patricia Griffith	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 243.29 per share.	21 Jan 2025	11,021	473,736 (0%)	0%	243.3	2,681,299	Common
Williams-Sonoma	Laura J. Alber	Director, PRESIDENT & CEO	Sale of securities on an exchange or to another person at price $ 206.58 per share.	21 Jan 2025	10,913	978,753 (1%)	0%	206.6	2,254,408	Common Stock
Wayfair Inc (Class A)	Steven Conine	Director, Co-Founder, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 47.87 per share.	21 Jan 2025	10,820	608,253 (0%)	0%	47.9	517,953	Class A Common Stock
Alignment Healthcare Inc	Hakan Kardes	Chief Experience Officer	Sale of securities on an exchange or to another person at price $ 14.99 per share.	21 Jan 2025	10,500	309,944	-	15.0	157,370	Common Stock
Minerals Tech Inc	D. J. Monagle	Group President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	10,476	32,070	-		-	Deferred Restricted Stock Units (DRSUs)
Gaming and Leisure Properties Inc	Matthew R. Demchyk	SVP, Chief Investment Officer	Sale of securities on an exchange or to another person at price $ 48.62 per share.	21 Jan 2025	10,474	71,757 (0%)	0%	48.6	509,246	Common Stock
Airbnb	Brian Chesky	Director, CEO and Chairman, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 132.53 per share.	21 Jan 2025	10,331	12,478,380	-	132.5	1,369,167	Class A Common Stock
Darden Restaurants	Matthew R. Broad	SVP General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	10,259	0	-		-	Stock Option (Right to Buy)
Darden Restaurants	Matthew R. Broad	SVP General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 107.05 per share.	21 Jan 2025	10,259	24,587 (0%)	0%	107.1	1,098,226	Common Stock
Credo Tech Grp Holding Ltd	Yat Tung Lam	Director, Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 79.88 per share.	21 Jan 2025	10,218	166,678	-	79.9	816,231	Ordinary Shares
Community West Bancshares.	James J. Kim	Director, CEO	Grant, award, or other acquisition of securities at price $ 18.87 per share.	21 Jan 2025	10,201	59,389 (0%)	0%	18.9	192,493	CWBC - Common Stock
Airbnb	Brian Chesky	Director, CEO and Chairman, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 131.69 per share.	21 Jan 2025	10,197	12,488,711	-	131.7	1,342,810	Class A Common Stock
Definitive Healthcare Corp (Class A)	Richard D. Booth	CHIEF FINANCIAL OFFICER	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.41 per share.	21 Jan 2025	10,192	688,546	-	4.4	44,947	Class A Common Stock
Natural Gas Services Grp Inc	Stephen C. Taylor	Director	Sale of securities on an exchange or to another person at price $ 29.01 per share.	21 Jan 2025	10,000	438,387 (3%)	0%	29.0	290,100	Common Stock
Argan Inc	William F. Leimkuhler	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	10,000	61,500	-		-	Option to Purchase Common Stock
BlackRock Results Board Meeting	J. Richard Kushel	Senior Managing Director	Sale of securities on an exchange or to another person at price $ 1010.00 per share.	21 Jan 2025	10,000	68,433 (0%)	0%	1010	10,100,000	Shares Of Common Stock (par Value $0.01 Per Share)
BlackRock Results Board Meeting	J. Richard Kushel	Senior Managing Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	10,000	57,142	-		-	Employee Stock Option (Right to Buy)
BlackRock Results Board Meeting	J. Richard Kushel	Senior Managing Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 513.50 per share.	21 Jan 2025	10,000	78,433 (0%)	0%	513.5	5,135,000	Shares Of Common Stock (par Value $0.01 Per Share)
Duolingo Inc (Class A)	Severin Hacker	Director, Chief Tech Officer, Co-Founder, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	10,000	30,252	-		-	Stock Option (Right to Buy)
Duolingo Inc (Class A)	Severin Hacker	Director, Chief Tech Officer, Co-Founder, Ten Percent Owner		21 Jan 2025	10,000	10,072	-	14.4	144,200	Class A Common Stock
Duolingo Inc (Class A)	Severin Hacker	Director, Chief Tech Officer, Co-Founder, Ten Percent Owner		21 Jan 2025	10,000	86,075	-		-	Class B Common Stock
Duolingo Inc (Class A)	Severin Hacker	Director, Chief Tech Officer, Co-Founder, Ten Percent Owner		21 Jan 2025	10,000	96,075	-		-	Class B Common Stock
Mirum Pharma Inc	Eric H. Bjerkholt	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	10,000	10,000	-		-	Restricted Stock Units
Mirum Pharma Inc	Joanne Quan	CHIEF MEDICAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	10,000	10,000	-		-	Restricted Stock Units
Power Soln Intl Inc	Gary Winemaster	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 41.09 per share.	21 Jan 2025	9,938	2,946,281 (12%)	0%	41.1	408,401	Common Stock
Credo Tech Grp Holding Ltd	Chi Fung Cheng	Director, Chief Technology Officer	Sale of securities on an exchange or to another person at price $ 81.66 per share.	21 Jan 2025	9,872	8,269,402	-	81.7	806,171	Ordinary Shares
Harmony Biosciences Holdings Inc	Jeffrey M. Dayno	Director, PRESIDENT, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	9,737	2,435	-		-	Stock Option
Credo Tech Grp Holding Ltd	Chi Fung Cheng	Director, Chief Technology Officer	Sale of securities on an exchange or to another person at price $ 78.94 per share.	21 Jan 2025	9,620	8,314,069	-	78.9	759,385	Ordinary Shares
Vital Farms Inc	Matthew O’Hayer	Director, EXECUTIVE CHAIRPERSON, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 43.73 per share.	21 Jan 2025	9,594	7,015,390	-	43.7	419,546	Common Stock
GoodRx Holdings Inc (Class A)	Scott W. Wagner	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	9,524	298,633	-		0	Class A Common Stock
W. P. Carey Inc	Gino M. Sabatini	Managing Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	9,495	608,152 (0%)	0%		0	Common Stock
Natural Gas Services Grp Inc	Stephen C. Taylor	Director	Sale of securities on an exchange or to another person at price $ 28.57 per share.	21 Jan 2025	9,400	448,387 (3%)	0%	28.6	268,549	Common Stock
Snowflake Inc (Class A)	Benoit Dageville	Director, President of Products	Gift of securities by or to the insider at price $ 0.00 per share.	21 Jan 2025	9,375	4,806,055	-		0	Class A Common Stock
Minerals Tech Inc	Brett Argirakis	Group President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	9,336	26,591	-		-	Deferred Restricted Stock Units (DRSUs)
Hims & Hers Health Inc (Class A)	Melissa Baird	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 28.67 per share.	21 Jan 2025	9,280	747,654	-	28.7	266,023	Class A Common Stock
JPMC Results Board Meeting	Robin Leopold	Head of Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	9,079	9,079	-		-	Restricted Stock Units
Minerals Tech Inc	D. J. Monagle	Group President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	8,997	8,997	-		-	Employee Stock Option (Right to Buy)
Progressive	Susan Patricia Griffith	Director, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 243.34 per share.	21 Jan 2025	8,960	484,757 (0%)	0%	243.3	2,180,326	Common
Synchrony Financial	Courtney Gentleman	See remarks	Grant, award, or other acquisition of securities at price $ 69.47 per share.	21 Jan 2025	8,925	26,821 (0%)	0%	69.5	620,020	Common Stock
SoFi Tech Inc	Kelli Keough	EVP, GBUL, SIPS	Sale of securities on an exchange or to another person at price $ 17.58 per share.	21 Jan 2025	8,914	178,811	-	17.6	156,730	Common Stock
Wayfair Inc (Class A)	Niraj Shah	Director, Chief Executive Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 47.81 per share.	21 Jan 2025	8,914	610,223 (0%)	0%	47.8	426,178	Class A Common Stock
Trade Desk Inc (Class A)	Jeffrey Terry Green	Director, President and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 121.98 per share.	21 Jan 2025	8,842	744,328 (1%)	0%	122.0	1,078,547	Class A Common Stock
Goldman Sachs Results Board Meeting	Denis P. Coleman III	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	8,820	25,308 (0%)	0%		-	Common Stock, par value $0.01 per share
Goldman Sachs Results Board Meeting	Denis P. Coleman III	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	8,820	0	-		-	Restricted Stock Units
USCB Fin Holdings Inc (Class A)	Robert B. Anderson	Executive VP and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	8,792	120,996	-		0	Class A Voting Common Stock
JPMC Results Board Meeting	Elena A. Korablina	Corporate Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	8,783	8,783	-		-	Restricted Stock Units
EverCommerce Inc	Eric Remer	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 10.21 per share.	21 Jan 2025	8,552	7,848,830	-	10.2	87,344	Common Stock
HubSpot Inc	Brian Halligan	Director, Executive Chair	Sale of securities on an exchange or to another person at price $ 709.29 per share.	21 Jan 2025	8,500	522,398 (1%)	0%	709.3	6,028,965	Common Stock
Goldman Sachs Results Board Meeting	Kathryn H. Ruemmler	Chief Legal Officer, GC	Payment of exercise price or tax liability using portion of securities received from the company at price $ 625.94 per share.	21 Jan 2025	8,439	17,087 (0%)	0%	625.9	5,282,308	Common Stock, par value $0.01 per share
Phreesia Inc	Allison Hoffman	General Counsel & Secretary	Sale of securities on an exchange or to another person at price $ 27.31 per share.	21 Jan 2025	8,426	146,126 (0%)	0%	27.3	230,120	Common Stock
Trade Desk Inc (Class A)	Jeffrey Terry Green	Director, President and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 123.95 per share.	21 Jan 2025	8,400	815,028 (2%)	0%	124.0	1,041,180	Class A Common Stock
Minerals Tech Inc	Jonathan J. Hastings	Senior Vice President		21 Jan 2025	8,362	26,608	-		-	Deferred Restricted Stock Units (DRSUs)
Argan Inc	William F. Leimkuhler	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.44 per share.	21 Jan 2025	8,345	46,789 (0%)	0%	30.4	254,022	Common Stock
Cricut Inc (Class A)	Kimball Shill	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	8,112	1,108,482	-		0	Class A Common Stock
Minerals Tech Inc	Brett Argirakis	Group President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	8,018	8,018	-		-	Employee Stock Option (Right to Buy)
Kinder Morgan (Class P) Results Board Meeting	Amy W. Chronis	Director	Grant, award, or other acquisition of securities at price $ 31.22 per share.	21 Jan 2025	8,010	32,005 (0%)	0%	31.2	250,072	Class P Common Stock
Vaxcyte Inc	Andrew L. Guggenhime	PRESIDENT AND CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.35 per share.	21 Jan 2025	8,000	117,491	-	5.4	42,800	Common Stock
Vaxcyte Inc	Andrew L. Guggenhime	PRESIDENT AND CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	8,000	254,827	-		-	Stock Option (right to buy)
Mirum Pharma Inc	Jolanda Howe	SVP, GLOBAL CONTROLLER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	7,973	7,973	-		-	Performance Restricted Stock Units
Phathom Pharma Inc	Azmi Nabulsi	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 6.59 per share.	21 Jan 2025	7,886	233,390 (0%)	0%	6.6	51,957	Common Stock
Reliance Global Grp Inc 10-year low	Yaakov Beyman	Exec VP, Insurance Division	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.88 per share.	21 Jan 2025	7,603	90,475 (0%)	0%	1.9	14,305	Common Stock
ReposiTrak	Randall K. Fields	Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 21.69 per share.	21 Jan 2025	7,500	327,000 (1%)	0%	21.7	162,710	Common Stock
United Therapeutics Corp	Michael Benkowitz	PRESIDENT AND COO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 111.00 per share.	21 Jan 2025	7,500	7,500 (0%)	0%	111	832,500	Common Stock
United Therapeutics Corp	Michael Benkowitz	PRESIDENT AND COO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	7,500	44,679	-		-	Stock Options
Northwest Natural Holding Co	David H. Anderson	Director, CEO	Sale of securities on an exchange or to another person at price $ 41.33 per share.	21 Jan 2025	7,500	137,742 (0%)	0%	41.3	309,968	Common Stock
Goldman Sachs Results Board Meeting	Kathryn H. Ruemmler	Chief Legal Officer, GC	Sale of securities on an exchange or to another person at price $ 634.69 per share.	21 Jan 2025	7,498	9,589 (0%)	0%	634.7	4,758,906	Common Stock, par value $0.01 per share
W. P. Carey Inc	Brooks G. Gordon	Managing Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	7,385	145,595 (0%)	0%		0	Common Stock
Reliance Global Grp Inc 10-year low	Yaakov Beyman	Exec VP, Insurance Division	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.96 per share.	21 Jan 2025	7,373	81,828 (0%)	0%	2.0	14,426	Common Stock
Velocity Fin Inc	Roland T. Kelly	Chief Legal Officer and GC	Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.82 per share.	21 Jan 2025	7,370	109,739 (0%)	0%	18.8	138,703	Common Stock
Minerals Tech Inc	Jonathan J. Hastings	Senior Vice President		21 Jan 2025	7,181	7,181	-		-	Employee Stock Option (Right to Buy)
Bed Bath & Beyond Inc	David J. Nielsen	PRESIDENT	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.00 per share.	21 Jan 2025	7,170	76,731 (0%)	0%	7	50,190	Common Stock
Bed Bath & Beyond Inc	Adrianne B. Lee	CHIEF FINANCIAL&ADMIN. OFFICER		21 Jan 2025	7,170	62,180 (0%)	0%	7	50,190	Common Stock
Linde	Stephen F. Angel	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	7,140	400,045 (0%)	0%		0	Ordinary Shares
Linde	Stephen F. Angel	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	7,140	108,382	-		-	Deferred Stock Units
HubSpot Inc	Brian Halligan	Director, Executive Chair	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	7,125	11,346	-		-	Stock Option (right to buy)
HubSpot Inc	Brian Halligan	Director, Executive Chair	Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.80 per share.	21 Jan 2025	7,125	530,898 (1%)	0%	52.8	376,200	Common Stock
USCB Fin Holdings Inc (Class A)	Nicholas Bustle	EVP and Chief Lending Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	6,947	43,575	-		0	Class A Voting Common Stock
Essential Properties Realty Trust Inc	Mark Patten	Executive VP, CFO & Treasurer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.46 per share.	21 Jan 2025	6,902	101,842 (0%)	0%	31.5	217,137	Common Stock
ADT Inc	Thomas M. Gartland	Director	Grant, award, or other acquisition of securities at price $ 7.28 per share.	21 Jan 2025	6,774	6,774	-	7.3	49,315	Restricted Stock Units
Velocity Fin Inc	Roland T. Kelly	Chief Legal Officer and GC	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	6,750	117,109 (0%)	0%		0	Common Stock
Minerals Tech Inc	Erik Aldag	Senior Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	6,733	17,429	-		-	Deferred Restricted Stock Units (DRSUs)
Definitive Healthcare Corp (Class A)	William Moschella	Chief Product & Tech Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.41 per share.	21 Jan 2025	6,711	479,840	-	4.4	29,596	Class A Common Stock
Alphatec Holdings Inc	Patrick S. Miles	Director, CEO	Sale of securities on an exchange or to another person at price $ 12.00 per share.	21 Jan 2025	6,687	5,501,715 (8%)	0%	12	80,244	Common Stock
SouthState Corp	Stephen Dean Young	Chief Strategy Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	6,686	29,978	-		-	Performance Share Units
Inhibikase Therapeutics Inc	Dennis N. Berman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	6,667	6,667	-		-	Stock Option (Right to Buy)
Inhibikase Therapeutics Inc	Dennis N. Berman	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	21 Jan 2025	6,667	0	-		-	Stock Option (Right to Buy)
Inhibikase Therapeutics Inc	Dennis N. Berman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	6,667	6,667	-		-	Stock Option (Right to Buy)
Inhibikase Therapeutics Inc	Dennis N. Berman	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	21 Jan 2025	6,667	0	-		-	Stock Option (Right to Buy)
Inhibikase Therapeutics Inc	Roy Freeman	Director		21 Jan 2025	6,667	0	-		-	Stock Option (Right to Buy)
Inhibikase Therapeutics Inc	Roy Freeman	Director		21 Jan 2025	6,667	0	-		-	Stock Option (Right to Buy)
Inhibikase Therapeutics Inc	Roy Freeman	Director		21 Jan 2025	6,667	6,667	-		-	Stock Option (Right to Buy)
Inhibikase Therapeutics Inc	Roy Freeman	Director		21 Jan 2025	6,667	6,667	-		-	Stock Option (Right to Buy)
Bed Bath & Beyond Inc	David J. Nielsen	PRESIDENT	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	6,667	65,218 (0%)	0%	0.0	1	Common Stock
Bed Bath & Beyond Inc	David J. Nielsen	PRESIDENT	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Jan 2025	6,667	41,929	-		-	Restricted Stock Units
Bed Bath & Beyond Inc	Adrianne B. Lee	CHIEF FINANCIAL&ADMIN. OFFICER		21 Jan 2025	6,667	41,929	-		-	Restricted Stock Units
Bed Bath & Beyond Inc	Adrianne B. Lee	CHIEF FINANCIAL&ADMIN. OFFICER		21 Jan 2025	6,667	50,667 (0%)	0%	0.0	1	Common Stock
Inhibikase Therapeutics Inc	Dennis N. Berman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	6,667	6,667	-		-	Stock Option (Right to Buy)
Inhibikase Therapeutics Inc	Dennis N. Berman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jan 2025	6,667	6,667	-		-	Stock Option (Right to Buy)
Phathom Pharma Inc	Molly Henderson	CFO and CBO	Sale of securities on an exchange or to another person at price $ 6.59 per share.	21 Jan 2025	6,583	93,546 (0%)	0%	6.6	43,371	Common Stock
Protara Therapeutics Inc	Jacqueline Zummo	Chf Scientific Operations Off	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.76 per share.	21 Jan 2025	6,554	95,585 (1%)	0%	4.8	31,197	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.

Insider trading for US stocks based on disclosures made made on Jan 21, 2025

Monitor US insider transactions and discover insider buying and selling of stocks on Jan 21, 2025.

The latest disclosure under SEC insider trading regulations was reported by Cibus Inc - Ordinary Shares - Class A., where the revocation of 4,000,000 Pre-Funded Warrant of common stock was executed . This transaction was reported to the Securities and Exchange Commission on Jan. 21, 2025.

Screeners based on Insider Trading parameters